History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

LDN 2017 Conference - Sunday Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Saturday Afternoon Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Saturday Morning Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Friday Afternoon Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Friday Morning Q&A (2017 Conference) (LDN, low dose naltrexone)

Stephen Dickson, BSC (hons) MRPharmS - Using an Old Drug to Trick the Immune System into Healing Itself (2018 Conference) (LDN, low dose naltrexone)

Angus Dalgleish, MD - The Role of LDN in the Management of Cancer (2017 Conference) (LDN, low dose naltrexone)

Prof. Angus Dalgleish: Well, I'm going to talk about LDN and cancer, and I'm coming from a very different, way of doing things. I was trained in some of my research at the Institute of Cancer Research, where you basically design drugs, put them in mice.

Nasha Winters, ND - Using LDN to Quell the Over-Reactive Autoimmune Conditions Triggered by Many of Today's Cancer Drugs (2019 Conference) (LDN, low dose naltrexone)

Cory Tichauer, ND - Immune Dysfunction in Post-Treatment Lyme Disease: Using Naltrexone to Balance Chronic Inflammation II (2019 Conference) (LDN, low dose naltrexone)